Linjie Ruan

Linjie Ruan

Auto-generated profile, based on publicly available information

Linjie Ruan

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in Phytomedicine
Verified
Journal Article
Open access
XLXin Li
Xin Li
WSWaimei Si
Waimei Si
YZYuan Zhang
Yuan Zhang
PYPeiwen Yang
Peiwen Yang
LRLinjie Ruan
Linjie Ruan
ZCZhen Chen
Zhen Chen
This study investigates the anti-tumor mechanisms of the natural triterpenoid Alpha-Heredin in pancreatic ductal adenocarcinoma, focusing on its dual effects on mitochondrial dynamics (via CAMKⅡ/DRP1 signaling) and ferroptosis induction. In vitro assays including CCK-8, EdU, colony formation, and flow cytometry were employed to assess Alpha-Heredin's effects on proliferation, migration, and cell cycle arrest. Functional studies utilized FerroOrange staining, MDA/GSH/SOD quantification, transmission electron microscopy (TEM), and MitoSOX/JC-1 assay to evaluate ferroptosis markers and mitochondrial function. Bioinformatics analysis integrated PDAC patient RNA-seq data (GSE85916) with GSVA and WGCNA to link mitochondrial dysfunction with ferroptosis pathways. Subcutaneous PDAC xenograft models treated with Alpha-Heredin (5/10 mg/kg) were analyzed for tumor growth, Ki-67/GPX4/xCT expression, and CAMKⅡ/DRP1 signaling in vivo. Alpha-Heredin dose-dependently suppressed PDAC proliferation and induced G0/G1 arrest. It inhibited CAMKⅡ/DRP1 phosphorylation, causing mitochondrial elongation, ROS accumulation, and cristae disruption. Ferroptosis induction was confirmed by iron overload, GSH/SOD depletion, and GPX4/xCT downregulation, reversible by Ferrostatin-1. In vivo, Alpha-Heredin (10 mg/kg) reduced tumor growth without systemic toxicity, while suppressing CAMKⅡ/DRP1 signaling and activating ferroptosis. Alpha-Heredin suppresses PDAC progression by dual targeting of mitochondrial fission and ferroptosis activation, offering a novel therapeutic strategy against pancreatic cancer.

3 October 2025 in JMIR Formative Research
Verified
Journal Article
Open access
HBHe Ba
He Ba
HDHaojie Du
Haojie Du
CCChien-shan Cheng
Chien-shan Cheng
YZYuan Zhang
Yuan Zhang
LRLinjie Ruan
Linjie Ruan
ZCZhen Chen
Zhen Chen
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Syndrome differentiation is crucial in traditional Chinese medicine (TCM) diagnosis and treatment, but it heavily relies on expert experience, limiting systematic standardization. Objective: This study developed and validated a BERT (bidirectional encoder representations from transformers)–based model, the traditional Chinese medicine pancreatic cancer syndrome differentiation bidirectional encoder representations from transformers (TCMPCSD-BERT), using in-house pancreatic cancer medical records, to digitalize expert knowledge and support standardized syndrome differentiation in TCM. Methods: A retrospective dataset of pancreatic cancer cases (2011-2024) from Fudan University Shanghai Cancer Center was annotated into 4 TCM syndrome types by 2 experts (Cohen κ=0.913). The proposed TCMPCSD-BERT model was compared with conventional models (long short-term memory and text convolutional neural network) embedded in TCM diagnostic tools and with large language models (LLMs; ChatGPT-4o, Kimi, Ernie Bot 4.0 Turbo, and Zhipu Qingyan) under a prompt engineering framework. Performance evaluation on in-house data was supplemented with attention visualizations and integrated gradients analyses for interpretability. The McNemar test assessed classification accuracy differences, while bootstrap 95% CIs quantified statistical uncertainty and stability. The Welch t test (2-tailed) was used to evaluate mean differences between TCMPCSD-BERT and the comparator models. Results: Among 6830 records, case counts were damp-heat syndrome (n=1694), spleen-deficiency syndrome (n=1185), damp-heat with spleen-deficiency syndrome (n=1178), and others (n=2773). On the test set, McNemar test showed significantly higher accuracy for TCMPCSD-BERT than the 3 baseline models and generally better performance than LLMs. In all comparisons, TCMPCSD-BERT achieved higher mean macroprecision, macrorecall, macro–F1-score, and accuracy, with nonoverlapping 95% bootstrap CIs and significant Welch t test results (P<.01). The model achieved a macroprecision of 0.935 (95% CI 0.918-0.951), macrorecall of 0.921 (95% CI 0.900-0.942), macro–F1-score of 0.927 (95% CI 0.908-0.945), and accuracy of 0.919 (95% CI 0.899-0.939). Attention visualizations suggested the model could capture less common TCM term associations, while integrated gradients highlighted high-attribution diagnostic features (eg, “gray-white stool” 0.933 in damp-heat syndrome; “indigestion” 1.204 in spleen-deficiency syndrome). Misclassification analyses indicated challenges in handling overlapping or atypical symptom presentations. Compared with LLMs, web-based platforms, and diagnostic instruments, TCMPCSD-BERT appeared to provide relatively higher accuracy, interpretability, and efficiency in processing long unstructured texts for syndrome differentiation. Conclusions: The TCMPCSD-BERT model shows potential for automated syndrome differentiation from unstructured clinical texts and broader application in TCM. Based on this study, it appears to improve operability over 4-diagnostic instruments and online platforms, and offers greater stability and accuracy than LLMs in specific tasks. However, these findings should be interpreted cautiously, given the subjectivity of syndrome definitions, data imbalance, and reliance on preprocessed, expert-annotated data. Further studies involving larger and more diverse populations are needed to validate its generalizability and support its broader application in real-world settings.

26 December 2024 in JMIR Preprints
Verified
Preprint
Open access
HBHe Ba
He Ba
HDHaojie Du
Haojie Du
CCChien-shan Cheng
Chien-shan Cheng
YZYuan Zhang
Yuan Zhang
LRLinjie Ruan
Linjie Ruan
ZCZhen Chen
Zhen Chen
BACKGROUND Syndrome differentiation is crucial in traditional Chinese medicine (TCM) diagnosis and treatment, but it heavily relies on expert experience, limiting systematic standardization. OBJECTIVE This study developed and validated a BERT (bidirectional encoder representations from transformers)–based model, the traditional Chinese medicine pancreatic cancer syndrome differentiation bidirectional encoder representations from transformers (TCMPCSD-BERT), using in-house pancreatic cancer medical records, to digitalize expert knowledge and support standardized syndrome differentiation in TCM. METHODS A retrospective dataset of pancreatic cancer cases (2011-2024) from Fudan University Shanghai Cancer Center was annotated into 4 TCM syndrome types by 2 experts (Cohen κ=0.913). The proposed TCMPCSD-BERT model was compared with conventional models (long short-term memory and text convolutional neural network) embedded in TCM diagnostic tools and with large language models (LLMs; ChatGPT-4o, Kimi, Ernie Bot 4.0 Turbo, and Zhipu Qingyan) under a prompt engineering framework. Performance evaluation on in-house data was supplemented with attention visualizations and integrated gradients analyses for interpretability. The McNemar test assessed classification accuracy differences, while bootstrap 95% CIs quantified statistical uncertainty and stability. The Welch t test (2-tailed) was used to evaluate mean differences between TCMPCSD-BERT and the comparator models. RESULTS Among 6830 records, case counts were damp-heat syndrome (n=1694), spleen-deficiency syndrome (n=1185), damp-heat with spleen-deficiency syndrome (n=1178), and others (n=2773). On the test set, McNemar test showed significantly higher accuracy for TCMPCSD-BERT than the 3 baseline models and generally better performance than LLMs. In all comparisons, TCMPCSD-BERT achieved higher mean macroprecision, macrorecall, macro–F1-score, and accuracy, with nonoverlapping 95% bootstrap CIs and significant Welch t test results (P<.01). The model achieved a macroprecision of 0.935 (95% CI 0.918-0.951), macrorecall of 0.921 (95% CI 0.900-0.942), macro–F1-score of 0.927 (95% CI 0.908-0.945), and accuracy of 0.919 (95% CI 0.899-0.939). Attention visualizations suggested the model could capture less common TCM term associations, while integrated gradients highlighted high-attribution diagnostic features (eg, “gray-white stool” 0.933 in damp-heat syndrome; “indigestion” 1.204 in spleen-deficiency syndrome). Misclassification analyses indicated challenges in handling overlapping or atypical symptom presentations. Compared with LLMs, web-based platforms, and diagnostic instruments, TCMPCSD-BERT appeared to provide relatively higher accuracy, interpretability, and efficiency in processing long unstructured texts for syndrome differentiation. CONCLUSIONS The TCMPCSD-BERT model shows potential for automated syndrome differentiation from unstructured clinical texts and broader application in TCM. Based on this study, it appears to improve operability over 4-diagnostic instruments and web-based platforms, and offers greater stability and accuracy than LLMs in specific tasks. However, these findings should be interpreted cautiously, given the subjectivity of syndrome definitions, data imbalance, and reliance on preprocessed, expert-annotated data. Further studies involving larger and more diverse populations are needed to validate its generalizability and support its broader application in real-world settings.

1 January 2026 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
WSWai-Mei Si
Wai-Mei Si
XLXin Li
Xin Li
YZYuan Zhang
Yuan Zhang
LYLi-Xia Yi
Li-Xia Yi
PYPei-Wen Yang
Pei-Wen Yang
ZCZhen Chen
Zhen Chen